Search For

Immunometabolic drivers of renal fibrosis and potential therapeutic targets in diabetic kidney disease

Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions

Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy

Liver fibrosis and diabetic peripheral neuropathy in individuals with type 2 diabetes mellitus: an observational, cross-sectional study

Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes

Exploring the regulatory impact of insulin on type I collagen synthesis in hepatic stellate cells through α5β1 integrin

Mouse models of primary sclerosing cholangitis: we just can't get enough

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1

Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity

Dysregulation of sphingolipid metabolism in liver fibrosis

Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis